Unlock stock picks and a broker-level newsfeed that powers Wall Street.
696,500.00
-14,000.00
(-1.97%)
At close: April 4 at 4:18:18 PM GMT+2
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 2 | 2 | 3 | 4 |
Avg. Estimate | 89.18B | 91.42B | 372B | 389.35B |
Low Estimate | 81.31B | 83.93B | 338.16B | 355.87B |
High Estimate | 97.04B | 98.91B | 394.2B | 410.3B |
Year Ago Sales | 89.87B | 93.65B | 371.43B | 372B |
Sales Growth (year/est) | -0.77% | -2.38% | 0.15% | 4.66% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
BRH.F | -- | -- | -- | -- |
S&P 500 | 6.68% | 6.74% | 9.91% | 14.34% |
Upgrades & Downgrades
Maintains | Keefe, Bruyette & Woods: Market Perform to Market Perform | 2/24/2025 |
Maintains | Keefe, Bruyette & Woods: Market Perform to Market Perform | 8/5/2024 |
Maintains | UBS: Buy to Buy | 2/28/2024 |
Maintains | Keefe, Bruyette & Woods: Market Perform to Market Perform | 2/26/2024 |
Downgrade | Edward Jones: Buy to Hold | 9/29/2023 |
Maintains | UBS: Buy to Buy | 8/7/2023 |